Outcomes of Patients with Differentiated Thyroid Carcinoma Following Initial Therapy

By J. Jonklaas, N. Sarlis, D. Litofsky, K. Ain, S. Bigos, J. Brierley, D. Cooper, B. Haugen, P. Ladenson, J. Magner and 5 more. Thyroid, 2006

677 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism, Surgery

View Paper: https://www.semanticscholar.org/paper/98139a902b95d4f3a7a602ceb17ec040b4d1b676

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. D. Cooper

Citations in the corpus

• Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer (2009, positive): “The National Thyroid Cancer Treatment Cooperative Study Group (NTCTCSG) report (214) of 2936 patients found after a median follow-up of 3 years, that near-total thyroidectomy followed by RAI therapy and aggressive thyroid hormone suppression therapy predicted improved overall survival of patients wi”
• Extent of Surgery Affects Survival for Papillary Thyroid Cancer (2007, background): “A recent study from the National Thyroid Cancer Treatment Cooperative Study Group (1987– 2001) reported a RAI utilization rate of 70%.(31) However, these data come from hospital chart abstractions from institutions that focus on thyroid cancer management, potentially explaining the higher observed u”